Re: Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks

Steven A. Kaplan

Research output: Contribution to journal › Comment/debate

Access to Document

@article{5cee4cb4dca64689983086d2d93f358e,

title = "Re: Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks",

author = "Kaplan, \{Steven A.\}",

year = "2011",

month = oct,

doi = "10.1016/s0022-5347(11)60427-8",

language = "English",

volume = "186",

pages = "1382--1383",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Wolters Kluwer Health",

number = "4",

}

TY - JOUR

T1 - Re

T2 - Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks

AU - Kaplan, Steven A.

PY - 2011/10

Y1 - 2011/10

UR - https://www.scopus.com/pages/publications/80052716496

U2 - 10.1016/s0022-5347(11)60427-8

DO - 10.1016/s0022-5347(11)60427-8

M3 - Comment/debate

AN - SCOPUS:80052716496

SN - 0022-5347

VL - 186

SP - 1382

EP - 1383

JO - Journal of Urology

JF - Journal of Urology

IS - 4

ER -